Literature DB >> 23509594

Ischemia-driven computed tomography-guided revascularization of chronic total occlusion missed by conventional angiography.

Maksymilian P Opolski1, Krzysztof Kotlinski, Jacek Wnuk, Cezary Kepka, Adam Witkowski.   

Abstract

Entities:  

Year:  2013        PMID: 23509594      PMCID: PMC3596665          DOI: 10.4070/kcj.2013.43.2.142

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


× No keyword cloud information.
A 71-year-old female with diabetes mellitus, a recent history of failed percutaneous revascularization of the chronic left anterior descending coronary artery (LAD) in-stent occlusion, and preserved left ventricular ejection fraction presented with persisting Canadian Cardiovascular Society class III angina. Coronary angiography failed to visualize the complete course of distal LAD (Fig. 1A and B, red squares). Single photon emission computed tomography showed significant ischaemia in the anteroseptal wall (Fig. 1C), while dual-source coronary computed tomography angiography (CCTA) demonstrated a wide and disease-free distal LAD (Fig. 1D, white squares). Following a balanced multidisciplinary discussion (Heart Team), an anastomosis between the left internal mammary artery and distal LAD was performed. The patient showed a complete resolution of ischaemia after 4 weeks from surgery (Fig. 2A), and the 6-month follow-up CCTA confirmed excellent patency of the bypass graft (Fig. 2B).
Fig. 1
Fig. 2
Coronary angiography-guided revascularization of chronic total occlusion (CTO) has been shown to improve long-term survival in patients with significant ischemia.1)2) However, since coronary angiography has considerable limitations related to failure of visualization of the distal CTO observed intraoperatively, it can be a major reason for deferral from CTO revascularization and poor patient prognosis.3)4) In our case, the presented improvement in myocardial ischemia after CT-guided revascularization of CTO missed by conventional angiography represents an indirect evidence of CCTA positive finding. This illustrates the rationale for performing CCTA in ischemia-producing CTO with ambiguous distal vessel anatomy in conventional angiography.
  4 in total

1.  Guidelines on myocardial revascularization.

Authors:  William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

2.  Coronary computed tomographic angiography for prediction of procedural and intermediate outcome of bypass grafting to left anterior descending artery occlusion with failed visualization on conventional angiography.

Authors:  Maksymilian P Opolski; Cezary Kepka; Stephan Achenbach; Zbigniew Juraszynski; Jerzy Pregowski; Mariusz Kruk; Marcin Niewada; Michal Jakubczyk; Anna Teresinska; Lidia Chojnowska; Zofia T Bilinska; Zofia Dzielinska; Marcin Demkow; Witold Ruzyllo; Zbigniew Chmielak; Adam Witkowski
Journal:  Am J Cardiol       Date:  2012-04-03       Impact factor: 2.778

3.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

4.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings.

Authors:  E N Arnett; J M Isner; D R Redwood; K M Kent; W P Baker; H Ackerstein; W C Roberts
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.